A randomized, double-blind, placebo-controlled, dose-finding trial with Lolium perenne peptide immunotherapy.
Allergy
; 73(4): 896-904, 2018 04.
Article
in En
| MEDLINE
| ID: mdl-29150857
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Conjunctivitis, Allergic
/
Rhinitis, Allergic, Seasonal
/
Desensitization, Immunologic
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Guideline
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
En
Journal:
Allergy
Year:
2018
Type:
Article
Affiliation country:
Germany